Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 28:13:924429.
doi: 10.3389/fphar.2022.924429. eCollection 2022.

Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer's Disease

Affiliations
Review

Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer's Disease

Qianyu Dong et al. Front Pharmacol. .

Abstract

Astragalus mongholicus Bunge (Fabaceae) (also known as Astragali radix-AR), a widely used herb by Traditional Chinese Medicine practitioners, possesses a wide range of pharmacological effects, and has been used to treat Alzheimer's disease (AD) historically. Its bioactive compounds are categorized into four families: saponins, flavonoids, polysaccharides, and others. AR's bioactive compounds are effective in managing AD through a variety of mechanisms, including inhibiting Aβ production, aggregation and tau hyperphosphorylation, protecting neurons against oxidative stress, neuroinflammation and apoptosis, promoting neural stem cell proliferation and differentiation and ameliorating mitochondrial dysfunction. This review aims to shed light upon the chemical constituents of AR and the mechanisms underlying the therapeutic effect of each compound in manging AD. Also presented are clinical studies which reported successful management of AD with AR and other herbs. These will be helpful for drug development and clinical application of AR to treat AD.

Keywords: Astragali radix; alzheimer’s disease; bioactive compound; molecular mechanism; traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Abdalla F. H., Cardoso A. M., Pereira L. B., Schmatz R., Gonçalves J. F., Stefanello N., et al. (2013). Neuroprotective Effect of Quercetin in Ectoenzymes and Acetylcholinesterase Activities in Cerebral Cortex Synaptosomes of Cadmium-Exposed Rats. Mol. Cell. Biochem. 381 (1-2), 1–8. 10.1007/s11010-013-1659-x - DOI - PubMed
    1. Abdalla F. H., Schmatz R., Cardoso A. M., Carvalho F. B., Baldissarelli J., de Oliveira J. S., et al. (2014). Quercetin Protects the Impairment of Memory and Anxiogenic-like Behavior in Rats Exposed to Cadmium: Possible Involvement of the Acetylcholinesterase and Na(+),K(+)-ATPase Activities. Physiol. Behav. 135, 152–167. 10.1016/j.physbeh.2014.06.008 - DOI - PubMed
    1. Ademosun A. O., Oboh G., Bello F., Ayeni P. O. (2016). Antioxidative Properties and Effect of Quercetin and its Glycosylated Form (Rutin) on Acetylcholinesterase and Butyrylcholinesterase Activities. J. Evid. Based. Complement. Altern. Med. 21 (4), NP11–7. 10.1177/2156587215610032 - DOI - PubMed
    1. Alzheimer's Association (2020). 2020 Alzheimer's Disease Facts and Figures. Alzheimers. Dement. 16 (3), 391–460. 10.1002/alz.12068 - DOI - PubMed
    1. Arnsten A. F. T., Datta D., Del Tredici K., Braak H. (2021). Hypothesis: Tau Pathology Is an Initiating Factor in Sporadic Alzheimer's Disease. Alzheimers. Dement. 17 (1), 115–124. 10.1002/alz.12192 - DOI - PMC - PubMed